Quantum BioPharma Previously Known as FSD Pharma (Nasdaq:HUGE) (CSE:HUGE) Invites Shareholders to Come Forward and Join Hands With the Company in the US700M$+ Court Case the Company Has Filed Against CIBC, RBC, and Others for Alleged Spoofing/Stock...

AccesswireNov 25 07:00 ET

Quantum Biopharma Announces That Sentinel Dosing Has Started for the Phase-1 Multiple Ascending Dose Clinical Trial for Lucid-21-302 (Lucid-Ms) in Australia

AccesswireOct 29 07:30 ET

Freedman Normand Friedland Files Market Manipulation Case On Behalf of Quantum Biopharma

PR NewswireOct 23 09:30 ET

Quantum BioPharma to Present at Global Growth and Investment Conference Presented by ArcStone Securities and Investments and Kingswood US

AccesswireSep 25 09:20 ET

Quantum Biopharma Signs an Agreement With Ingenu CRO to Conduct a Clinical Study to Observe Disease Progression in Patients With Primary Progressive Multiple Sclerosis

AccesswireSep 9 07:30 ET

Quantum BioPharma Ltd. (QNTM) Announces Key Milestones; Price Target $12.80

AccesswireAug 30 10:30 ET